1
|
Chirsir P, Palm EH, Baskaran S, Schymanski EL, Wang Z, Wolf R, Hale SE, Arp HPH. Grouping strategies for assessing and managing persistent and mobile substances. ENVIRONMENTAL SCIENCES EUROPE 2024; 36:102. [PMID: 38784824 PMCID: PMC11108893 DOI: 10.1186/s12302-024-00919-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 01/31/2024] [Accepted: 04/24/2024] [Indexed: 05/25/2024]
Abstract
Background Persistent, mobile and toxic (PMT), or very persistent and very mobile (vPvM) substances are a wide class of chemicals that are recalcitrant to degradation, easily transported, and potentially harmful to humans and the environment. Due to their persistence and mobility, these substances are often widespread in the environment once emitted, particularly in water resources, causing increased challenges during water treatment processes. Some PMT/vPvM substances such as GenX and perfluorobutane sulfonic acid have been identified as substances of very high concern (SVHCs) under the European Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation. With hundreds to thousands of potential PMT/vPvM substances yet to be assessed and managed, effective and efficient approaches that avoid a case-by-case assessment and prevent regrettable substitution are necessary to achieve the European Union's zero-pollution goal for a non-toxic environment by 2050. Main Substance grouping has helped global regulation of some highly hazardous chemicals, e.g., through the Montreal Protocol and the Stockholm Convention. This article explores the potential of grouping strategies for identifying, assessing and managing PMT/vPvM substances. The aim is to facilitate early identification of lesser-known or new substances that potentially meet PMT/vPvM criteria, prompt additional testing, avoid regrettable use or substitution, and integrate into existing risk management strategies. Thus, this article provides an overview of PMT/vPvM substances and reviews the definition of PMT/vPvM criteria and various lists of PMT/vPvM substances available. It covers the current definition of groups, compares the use of substance grouping for hazard assessment and regulation, and discusses the advantages and disadvantages of grouping substances for regulation. The article then explores strategies for grouping PMT/vPvM substances, including read-across, structural similarity and commonly retained moieties, as well as the potential application of these strategies using cheminformatics to predict P, M and T properties for selected examples. Conclusions Effective substance grouping can accelerate the assessment and management of PMT/vPvM substances, especially for substances that lack information. Advances to read-across methods and cheminformatics tools are needed to support efficient and effective chemical management, preventing broad entry of hazardous chemicals into the global market and favouring safer and more sustainable alternatives.
Collapse
Affiliation(s)
- Parviel Chirsir
- Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 6 Avenue du Swing, 4367 Belvaux, Luxembourg
| | - Emma H. Palm
- Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 6 Avenue du Swing, 4367 Belvaux, Luxembourg
| | - Sivani Baskaran
- Department of Environmental Engineering, Norwegian Geotechnical Institute, 0806 Oslo, Norway
| | - Emma L. Schymanski
- Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 6 Avenue du Swing, 4367 Belvaux, Luxembourg
| | - Zhanyun Wang
- Technology and Society Laboratory, Empa-Swiss Federal Laboratories for Materials Science and Technology, 9014 St. Gallen, Switzerland
| | - Raoul Wolf
- Department of Environmental Engineering, Norwegian Geotechnical Institute, 0806 Oslo, Norway
| | - Sarah E. Hale
- TZW: DVGW-Technologiezentrum Wasser (German Water Centre), Karlsruher Straße 84, 76139 Karlsruhe, Germany
| | - Hans Peter H. Arp
- Department of Environmental Engineering, Norwegian Geotechnical Institute, 0806 Oslo, Norway
- Department of Chemistry, Norwegian University of Science and Technology (NTNU), 7491 Trondheim, Norway
| |
Collapse
|
2
|
Iribarne-Durán LM, Castillero-Rosales I, Peinado FM, Artacho-Cordón F, Molina-Molina JM, Medianero E, Nicolás-Delgado SI, Sánchez-Pinzón L, Núñez-Samudio V, Vela-Soria F, Olea N, Alvarado-González NE. Placental concentrations of xenoestrogenic organochlorine pesticides and polychlorinated biphenyls and assessment of their xenoestrogenicity in the PA-MAMI mother-child cohort. ENVIRONMENTAL RESEARCH 2024; 241:117622. [PMID: 37977273 DOI: 10.1016/j.envres.2023.117622] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/26/2023] [Revised: 11/05/2023] [Accepted: 11/07/2023] [Indexed: 11/19/2023]
Abstract
BACKGROUND Organochlorine pesticides (OCPs) and polychlorinated biphenyls (PCB), they have contributed to the exposure of women to persistent organic pollutants (POPs). These compounds can cross the placental barrier and interfere with the hormonal system of newborns. AIM To determine concentrations of OCPs and PCBs and their xenoestrogenic activity in placentas of women from the PA-MAMI cohort of Panama. METHODS Thirty-nine placenta samples from women in the Azuero peninsula (Panama) were analyzed. Five OCPs [p-p'-dichlorodiphenyldichloroethylene (p-p'-DDE), beta-hexachlorohexane (β-HCH), γ-hexachlorohexane (lindane), hexachlorobenzene (HCB) and mirex] and three PCB congeners (PCB-138, PCB-153 and PCB-180) were quantified in placenta extracts. The xenoestrogenic activity of extracts was assessed with the E-Screen bioassay to estimate the total effective xenoestrogen burden (TEXB). RESULTS All placental samples were positive for at least three POP residues and >70% for at least six. The frequencies of quantified OCPs ranged from 100% for p,p'-DDE and HCB to 30.8% for β-HCH. The highest median concentration was for lindane (380.0 pg/g placenta), followed by p,p'-DDE (280.0 pg/g placenta), and HCB (90.0 pg/g placenta). Exposure to p,p'-DDE was associated with greater meat consumption, suggesting that animal fat is a major source of exposure to DDT metabolites. The frequency of detected PCBs ranged between 70 and 90%; the highest median concentration was for PCB 138 (17.0 pg/g placenta), followed by PCB 153 (16.0 pg/g placenta). All placentas were positive in the estrogenicity bioassay with a median TEXB-α of 0.91 pM Eeq/g of placenta. Exposure to lindane was positively associated with the xenoestrogenicity of TEXB- α, whereas this association was negative in the case of exposure to PCB 153. CONCLUSIONS To our best knowledge, this study contributes the first evidence on the presence of POPs and xenoestrogenic burden in placentas from Latin-American women. Given concerns about the consequences of prenatal exposure to these compounds on children's health, preventive measures are highly recommended to eliminate or minimize the risk of OCP exposure during pregnancy.
Collapse
Affiliation(s)
- L M Iribarne-Durán
- Instituto de Investigación Biosanitaria de Granada (ibs. GRANADA), E-18012, Granada, Spain.
| | | | - F M Peinado
- Instituto de Investigación Biosanitaria de Granada (ibs. GRANADA), E-18012, Granada, Spain
| | - F Artacho-Cordón
- Instituto de Investigación Biosanitaria de Granada (ibs. GRANADA), E-18012, Granada, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), E- 28029, Madrid, Spain; Departamento de Radiología y Medicina Física, Universidad de Granada, E- 18016, Granada, Spain
| | - J M Molina-Molina
- Instituto de Investigación Biosanitaria de Granada (ibs. GRANADA), E-18012, Granada, Spain
| | - E Medianero
- Departamento de Ciencias Ambientales, Facultad de Ciencias Naturales, Exactas y Tecnología, Universidad de Panamá, Panama; Secretaria Nacional de Ciencia, Tecnología e Innovación (SENACYT), Panama
| | - S I Nicolás-Delgado
- Departamento de Ginecología y Obstetricia, Hospital Joaquín Pablo Franco Sayas, Ministerio de Salud, Los Santos, Panama
| | - L Sánchez-Pinzón
- Clínica de Cesación de Tabaco y Clínica del Empleado Local, Región de Salud de Azuero, Ministerio de Salud, Los Santos, Panama
| | - V Núñez-Samudio
- Departamento de Salud Pública, Sección de Epidemiología, Región de Salud de Herrera, Ministerio de Salud, Panama; Instituto de Ciencias Médicas, Las Tablas, Los Santos, Panama
| | - F Vela-Soria
- Instituto de Investigación Biosanitaria de Granada (ibs. GRANADA), E-18012, Granada, Spain
| | - N Olea
- Instituto de Investigación Biosanitaria de Granada (ibs. GRANADA), E-18012, Granada, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), E- 28029, Madrid, Spain; Departamento de Radiología y Medicina Física, Universidad de Granada, E- 18016, Granada, Spain; Unidad de Medicina Nuclear, Hospital Universitario San Cecilio, E- 18016, Granada, Spain
| | - N E Alvarado-González
- Instituto Especializado de Análisis (IEA), Vicerrectoría de Investigación y Postgrado, Universidad de Panamá, Panama
| |
Collapse
|
3
|
Sadighara P, Mahdavi V, Tahmasebi R, Saatloo NV. Cell proliferation assay for determination of estrogenic components in food: a systematic review. REVIEWS ON ENVIRONMENTAL HEALTH 2023; 38:621-627. [PMID: 35934880 DOI: 10.1515/reveh-2022-0035] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/17/2022] [Accepted: 06/29/2022] [Indexed: 06/15/2023]
Abstract
Due to the widespread use and environmental pollution of estrogenic chemicals, the need for screening tests to detect these compounds is felt more than ever. These compounds lead to cell proliferation. Therefore, studies used cell proliferation to evaluate estrogenic compounds was studied in this systematic review. This systematic review was performed with the keywords; DNA proliferation, cell proliferation, estrogenic component, estrogen, food, bioassay, screening, and detection. After initial screening and full text quality assessment, 16 manuscripts were selected and data were extracted. Four cell lines, MCF-7, MDA-MB-231, Ishikawa, and T47D cells were used in the studies. MCF-7 was more sensitive to estrogenic compounds than other lines. Most of the samples studied were plant compounds and mycotoxins and substances that migrate from packaging to food. This screening test is valid and has similar results as others.
Collapse
Affiliation(s)
- Parisa Sadighara
- Department of Environmental Health, Food Safety Division, Faculty of Public Health, Tehran University of Medical Sciences, Tehran, Iran
| | - Vahideh Mahdavi
- Iranian Research Institute of Plant Protection (IRIPP), Agricultural Research, Education and Extension Organization (AREEO), Tehran, Iran
| | - Rahele Tahmasebi
- Research and Department of Chromatography, Iranian Academic Center for Education, Culture and Research (ACECR), Urmia, Iran
| | - Naiema Vakili Saatloo
- Department of Food Hygiene and Quality Control, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran
| |
Collapse
|
4
|
Wielsøe M, Molina-Molina JM, Rodríguez-Carrillo A, Mustieles V, Olea N, Fernandez MF, Bonefeld-Jørgensen EC. Xeno-estrogenic activity of real-life mixtures of perfluoroalkylated substances in human placenta homogenates. Reprod Toxicol 2023; 120:108444. [PMID: 37473930 DOI: 10.1016/j.reprotox.2023.108444] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2023] [Revised: 07/14/2023] [Accepted: 07/17/2023] [Indexed: 07/22/2023]
Abstract
Humans are simultaneously exposed to complex chemical mixtures, and its combined effect can affect human health. As part of the HBM4EU project, the actual mixture of perfluoroalkylated substances (PFAS) in 25 human placenta samples was extracted by chromatographic methods and assessed for xeno-estrogenic activity using two in-vitro bioassays: the estrogen receptor transactivity and the E-Screen assay. Most of the PFAS extracts displayed xeno-estrogenic activity, in one or both assays. The xeno-estrogenic activities in the two bioassays were not correlated, but both assays showed an overall negative correlation with placenta concentrations of single PFAS. Xeno-estrogenic activities were significantly related to maternal characteristics; being higher in young, smokers and primiparous women, but not with fetal growth (birth weight, birth length, head circumference, gestational age, placenta weight). The presented extraction method can be used to study the combined effect of real-life mixtures of PFAS in relation to health outcomes in large-scale human biomonitoring studies.
Collapse
Affiliation(s)
- Maria Wielsøe
- Centre for Arctic Health & Molecular Epidemiology, Department of Public Health, Aarhus University, DK-8000 Aarhus, Denmark.
| | - Jose-Manuel Molina-Molina
- Center for Biomedical Research (CIBM) & Department of Radiology and Physical Medicine, School of Medicine, University of Granada, E-18016 Granada, Spain; Instituto de Investigación Biosanitaria (ibs.GRANADA), E-18012 Granada, Spain
| | - Andrea Rodríguez-Carrillo
- Center for Biomedical Research (CIBM) & Department of Radiology and Physical Medicine, School of Medicine, University of Granada, E-18016 Granada, Spain; Instituto de Investigación Biosanitaria (ibs.GRANADA), E-18012 Granada, Spain
| | - Vicente Mustieles
- Center for Biomedical Research (CIBM) & Department of Radiology and Physical Medicine, School of Medicine, University of Granada, E-18016 Granada, Spain; Instituto de Investigación Biosanitaria (ibs.GRANADA), E-18012 Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), E-28029, Spain
| | - Nicolas Olea
- Center for Biomedical Research (CIBM) & Department of Radiology and Physical Medicine, School of Medicine, University of Granada, E-18016 Granada, Spain; Instituto de Investigación Biosanitaria (ibs.GRANADA), E-18012 Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), E-28029, Spain
| | - Mariana F Fernandez
- Center for Biomedical Research (CIBM) & Department of Radiology and Physical Medicine, School of Medicine, University of Granada, E-18016 Granada, Spain; Instituto de Investigación Biosanitaria (ibs.GRANADA), E-18012 Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), E-28029, Spain
| | - Eva Cecilie Bonefeld-Jørgensen
- Centre for Arctic Health & Molecular Epidemiology, Department of Public Health, Aarhus University, DK-8000 Aarhus, Denmark; Greenland Centre for Health Research, University of Greenland, Nuuk, GRL-3905 Nuussuaq, Greenland
| |
Collapse
|
5
|
Rodríguez-Carrillo A, Mustieles V, Salamanca-Fernández E, Olivas-Martínez A, Suárez B, Bajard L, Baken K, Blaha L, Bonefeld-Jørgensen EC, Couderq S, D'Cruz SC, Fini JB, Govarts E, Gundacker C, Hernández AF, Lacasaña M, Laguzzi F, Linderman B, Long M, Louro H, Neophytou C, Oberemn A, Remy S, Rosenmai AK, Saber AT, Schoeters G, Silva MJ, Smagulova F, Uhl M, Vinggaard AM, Vogel U, Wielsøe M, Olea N, Fernández MF. Implementation of effect biomarkers in human biomonitoring studies: A systematic approach synergizing toxicological and epidemiological knowledge. Int J Hyg Environ Health 2023; 249:114140. [PMID: 36841007 DOI: 10.1016/j.ijheh.2023.114140] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2022] [Revised: 02/08/2023] [Accepted: 02/15/2023] [Indexed: 02/26/2023]
Abstract
Human biomonitoring (HBM) studies have highlighted widespread daily exposure to environmental chemicals. Some of these are suspected to contribute to adverse health outcomes such as reproductive, neurological, and metabolic disorders, among other developmental and chronic impairments. One of the objectives of the H2020 European Human Biomonitoring Initiative (HBM4EU) was the development of informative effect biomarkers for application in a more systematic and harmonized way in large-scale European HBM studies. The inclusion of effect biomarkers would complement exposure data with mechanistically-based information on early and late adverse effects. For this purpose, a stepwise strategy was developed to identify and implement a panel of validated effect biomarkers in European HBM studies. This work offers an overview of the complete procedure followed, from comprehensive literature search strategies, selection of criteria for effect biomarkers and their classification and prioritization, based on toxicological data and adverse outcomes, to pilot studies for their analytical, physiological, and epidemiological validation. We present the example of one study that demonstrated the mediating role of the effect biomarker status of brain-derived neurotrophic factor BDNF in the longitudinal association between infant bisphenol A (BPA) exposure and behavioral function in adolescence. A panel of effect biomarkers has been implemented in the HBM4EU Aligned Studies as main outcomes, including traditional oxidative stress, reproductive, and thyroid hormone biomarkers. Novel biomarkers of effect, such as DNA methylation status of BDNF and kisspeptin (KISS) genes were also evaluated as molecular markers of neurological and reproductive health, respectively. A panel of effect biomarkers has also been applied in HBM4EU occupational studies, such as micronucleus analysis in lymphocytes and reticulocytes, whole blood comet assay, and malondialdehyde, 8-oxo-2'-deoxyguanosine and untargeted metabolomic profile in urine, to investigate, for example, biological changes in response to hexavalent chromium Cr(VI) exposure. The use of effect biomarkers in HBM4EU has demonstrated their ability to detect early biological effects of chemical exposure and to identify subgroups that are at higher risk. The roadmap developed in HBM4EU confirms the utility of effect biomarkers, and support one of the main objectives of HBM research, which is to link exposure biomarkers to mechanistically validated effect and susceptibility biomarkers in order to better understand the public health implications of human exposure to environmental chemicals.
Collapse
Affiliation(s)
- Andrea Rodríguez-Carrillo
- Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016, Granada, Spain
| | - Vicente Mustieles
- Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Spain
| | - Elena Salamanca-Fernández
- Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016, Granada, Spain.
| | - Alicia Olivas-Martínez
- Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain
| | - Beatriz Suárez
- Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain
| | - Lola Bajard
- RECETOX, Faculty of Science, Masaryk University, Kamenice 5, CZ62500, Brno, Czech Republic
| | - Kirsten Baken
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | - Ludek Blaha
- RECETOX, Faculty of Science, Masaryk University, Kamenice 5, CZ62500, Brno, Czech Republic
| | - Eva Cecilie Bonefeld-Jørgensen
- Centre for Arctic Health & Molecular Epidemiology, Department of Public Health Aarhus University, Denmark; Greenland Centre for Health Research, University of Greenland, Nuuk, Greenland
| | - Stephan Couderq
- Physiologie Moléculaire et Adaptation, Département "Adaptation du Vivant", UMR 7221 MNHN/CNRS, Muséum National d'Histoire Naturelle, Paris, 75005, France
| | - Shereen Cynthia D'Cruz
- Univ Rennes, EHESP, Inserm, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, F-35000, Rennes, France
| | - Jean-Baptiste Fini
- Physiologie Moléculaire et Adaptation, Département "Adaptation du Vivant", UMR 7221 MNHN/CNRS, Muséum National d'Histoire Naturelle, Paris, 75005, France
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | - Claudia Gundacker
- Institute of Medical Genetics, Medical University of Vienna, Waehringer Strasse 10, A-1090, Vienna, Austria
| | - Antonio F Hernández
- Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Spain; Department of Legal Medicine and Toxicology, University of Granada School of Medicine, Granada, Spain
| | - Marina Lacasaña
- Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Spain; Department of Legal Medicine and Toxicology, University of Granada School of Medicine, Granada, Spain
| | - Federica Laguzzi
- Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden
| | - Birgitte Linderman
- Department of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
| | - Manhai Long
- Centre for Arctic Health & Molecular Epidemiology, Department of Public Health Aarhus University, Denmark; Greenland Centre for Health Research, University of Greenland, Nuuk, Greenland
| | - Henriqueta Louro
- National Institute of Health Doutor Ricardo Jorge (INSA), Human Genetics Department, Toxicogenomics and Human Health (ToxOmics), NOVA Medical School/FCM, Universidade Nova de Lisboa, Av. Padre Cruz, 1649-016, Lisbon, Portugal
| | | | - Axel Oberemn
- German Federal Institute for Risk Assessment, Max-Dohrn-Straße 8-10, 10589, Berlin, Germany
| | - Sylvie Remy
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | | | | | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium; Department of Biomedical Sciences and Toxicological Center, University of Antwerp, Belgium
| | - Maria Joao Silva
- National Institute of Health Doutor Ricardo Jorge (INSA), Human Genetics Department, Toxicogenomics and Human Health (ToxOmics), NOVA Medical School/FCM, Universidade Nova de Lisboa, Av. Padre Cruz, 1649-016, Lisbon, Portugal
| | - Fatima Smagulova
- Univ Rennes, EHESP, Inserm, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, F-35000, Rennes, France
| | - Maria Uhl
- Environment Agency Austria (EAA), Vienna, Austria
| | - Anne Marie Vinggaard
- National Food Institute, Technical University of Denmark, 2800 Kgs, Lyngby, Denmark
| | - Ulla Vogel
- National Food Institute, Technical University of Denmark, 2800 Kgs, Lyngby, Denmark; The National Research Centre for the Working Environment, Copenhagen, Denmark
| | - Maria Wielsøe
- Centre for Arctic Health & Molecular Epidemiology, Department of Public Health Aarhus University, Denmark
| | - Nicolás Olea
- Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Spain
| | - Mariana F Fernández
- Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Spain.
| |
Collapse
|
6
|
Lobo Vicente J, Ganzleben C, Gasol R, Marnane I, Gilles L, Buekers J, Bessems J, Colles A, Gerofke A, David M, Barouki R, Uhl M, Sepai O, Loots I, Crabbé A, Coertjens D, Kolossa-Gehring M, Schoeters G. HBM4EU results support the Chemicals' Strategy for Sustainability and the Zero-Pollution Action Plan. Int J Hyg Environ Health 2023; 248:114111. [PMID: 36706581 DOI: 10.1016/j.ijheh.2023.114111] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2022] [Revised: 12/12/2022] [Accepted: 01/05/2023] [Indexed: 01/27/2023]
Abstract
One of the major goals of the European Human Biomonitoring Initiative (HBM4EU) was to bridge the gap between science and policy by consulting both policy makers and national scientists and generating evidence of the actual exposure of residents to chemicals and whether that exposure would be suggest a potential health risk. Residents' perspectives on chemical exposure and risk were also investigated. HBM4EU's research was designed to answer specific short-term and long-term policy questions at national and European levels, and for its results to directly support regulatory action on chemicals. A strategy was established to prioritise chemicals for analysis in human matrices, with a total of 18 substances/substance groups chosen to be investigated throughout the five-and a -half-year project. HBM4EU produced new evidence of human exposure levels, developed reference values for exposure, investigated determinants of exposure and derived health-based guidance values for those substances. In addition, HBM4EU promoted the use of human biomonitoring data in chemical risk assessment and developed innovative tools and methods linking chemicals to possible health impacts, such as effect biomarkers. Furthermore, HBM4EU advanced understand of effects from combined exposures and methods to identify emerging chemicals. With the aim of supporting policy implementation, science-to-policy workshops were organised, providing opportunities for joint reflection and dialogue on research results. I, and indicators were developed to assess temporal and spatial patterns in the exposure of European population. A sustainable human biomonitoring monitoring framework, producing comparable quality assured data would allow: the evaluation of time trends; the exploration of spatial trends: the evaluation of the influence of socio-economic conditions on chemical exposure. Therefore, such a framework should be included in the European Chemicals' Strategy for Sustainability and the data would support the Zero Pollution Action Plan.
Collapse
Affiliation(s)
- Joana Lobo Vicente
- European Environment Agency (EEA), Kongens Nytorv 6, 1050 Copenhagen K, Denmark.
| | - Catherine Ganzleben
- European Environment Agency (EEA), Kongens Nytorv 6, 1050 Copenhagen K, Denmark
| | - Roser Gasol
- European Environment Agency (EEA), Kongens Nytorv 6, 1050 Copenhagen K, Denmark
| | - Ian Marnane
- European Environment Agency (EEA), Kongens Nytorv 6, 1050 Copenhagen K, Denmark
| | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - Jurgen Buekers
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - Jos Bessems
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - Ann Colles
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - Antje Gerofke
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Madlen David
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | | | - Maria Uhl
- Environment Agency, Spittelauer Lände 5, Vienna, 1090, Austria
| | - Ovnair Sepai
- United Kingdom Health Security Agency, Harwell Science Park, Chilton, OX11 0RQ, UK
| | - Ilse Loots
- University of Antwerp, Department of Sociology (CRESC and IMDO), Sint-Jacobstraat 2, 2000, Antwerp, Belgium
| | - Ann Crabbé
- University of Antwerp, Department of Sociology (CRESC and IMDO), Sint-Jacobstraat 2, 2000, Antwerp, Belgium
| | - Dries Coertjens
- University of Antwerp, Department of Sociology (CRESC and IMDO), Sint-Jacobstraat 2, 2000, Antwerp, Belgium
| | | | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium; University of Antwerp, Dept of Biomedical Sciences and Toxicological Centre, Universiteitsplein 1, 2610, Wilrijk, Belgium
| |
Collapse
|
7
|
Ma Y, Taxvig C, Rodríguez-Carrillo A, Mustieles V, Reiber L, Kiesow A, Löbl NM, Fernández MF, Hansen TVA, Valente MJ, Kolossa-Gehring M, David M, Vinggaard AM. Human risk associated with exposure to mixtures of antiandrogenic chemicals evaluated using in vitro hazard and human biomonitoring data. ENVIRONMENT INTERNATIONAL 2023; 173:107815. [PMID: 36822008 PMCID: PMC10030311 DOI: 10.1016/j.envint.2023.107815] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/23/2022] [Revised: 02/01/2023] [Accepted: 02/09/2023] [Indexed: 06/18/2023]
Abstract
BACKGROUND Scientific evidence for underestimated toxicity from unintentional exposure to chemical mixtures is mounting. Yet, harmonized approaches on how to assess the actual risk of mixtures is lacking. As part of the European Joint programme 'Human Biomonitoring for Europe' we explored a novel methodology for mixture risk assessment of chemicals affecting male reproductive function. METHODOLOGY We explored a methodology for chemical mixture risk assessment based on human in vitro data combined with human exposure data, thereby circumventing the drawbacks of using hazard data from rodents and estimated exposure intake levels. Human androgen receptor (hAR) antagonism was selected as the most important molecular initiating event linked to adverse outcomes on male reproductive health. RESULTS Our work identified 231 chemicals able to interfere with hAR activity. Among these were 61 finally identified as having both reliable hAR antagonist and human biomonitoring data. Calculation of risk quotients indicated that PCBs (118, 138, 157), phthalates (BBP, DBP, DIBP), benzophenone-3, PFOS, methylparaben, triclosan, some pesticides (i.e cypermethrin, β-endosulfan, methylparathion, p,p-DDE), and a PAH metabolite (1-hydroxypyrene) contributed to the mixture effect. The major chemical mixture drivers were PCB 118, BBP, PFOS, DBP, and the UV filter benzophenone-3, together contributing with 75% of the total mixture effect that was primarily driven by high exposure values. CONCLUSIONS This viable way forward for mixture risk assessment of chemicals has the advantages of (1) being a more comprehensive mixture risk assessment also covering data-poor chemicals, and (2) including human data only. However, the approach is subjected to uncertainties in terms of in vitro to in vivo extrapolation, it is not ready for decision making, and needs further development. Still, the results indicate a concern for adverse effects on reproductive function in highly exposed boys, especially when considering additional exposure to data-poor chemicals and chemicals acting by other mechanisms of action.
Collapse
Affiliation(s)
- Yanying Ma
- National Food Institute, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark
| | - Camilla Taxvig
- National Food Institute, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark
| | - Andrea Rodríguez-Carrillo
- Center for Biomedical Research (CIBM), University of Granada, Spain; Instituto de Investigación Biosanitaria Ibs Granada, Spain
| | - Vicente Mustieles
- Center for Biomedical Research (CIBM), University of Granada, Spain; Instituto de Investigación Biosanitaria Ibs Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), 18100, Spain
| | | | | | | | - Mariana F Fernández
- Center for Biomedical Research (CIBM), University of Granada, Spain; Instituto de Investigación Biosanitaria Ibs Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), 18100, Spain
| | | | - Maria João Valente
- National Food Institute, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark
| | | | | | - Anne Marie Vinggaard
- National Food Institute, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark.
| |
Collapse
|
8
|
Zare Jeddi M, Hopf NB, Louro H, Viegas S, Galea KS, Pasanen-Kase R, Santonen T, Mustieles V, Fernandez MF, Verhagen H, Bopp SK, Antignac JP, David A, Mol H, Barouki R, Audouze K, Duca RC, Fantke P, Scheepers P, Ghosh M, Van Nieuwenhuyse A, Lobo Vicente J, Trier X, Rambaud L, Fillol C, Denys S, Conrad A, Kolossa-Gehring M, Paini A, Arnot J, Schulze F, Jones K, Sepai O, Ali I, Brennan L, Benfenati E, Cubadda F, Mantovani A, Bartonova A, Connolly A, Slobodnik J, Bruinen de Bruin Y, van Klaveren J, Palmen N, Dirven H, Husøy T, Thomsen C, Virgolino A, Röösli M, Gant T, von Goetz N, Bessems J. Developing human biomonitoring as a 21st century toolbox within the European exposure science strategy 2020-2030. ENVIRONMENT INTERNATIONAL 2022; 168:107476. [PMID: 36067553 DOI: 10.1016/j.envint.2022.107476] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/07/2022] [Revised: 07/28/2022] [Accepted: 08/12/2022] [Indexed: 06/15/2023]
Abstract
Human biomonitoring (HBM) is a crucial approach for exposure assessment, as emphasised in the European Commission's Chemicals Strategy for Sustainability (CSS). HBM can help to improve chemical policies in five major key areas: (1) assessing internal and aggregate exposure in different target populations; 2) assessing exposure to chemicals across life stages; (3) assessing combined exposure to multiple chemicals (mixtures); (4) bridging regulatory silos on aggregate exposure; and (5) enhancing the effectiveness of risk management measures. In this strategy paper we propose a vision and a strategy for the use of HBM in chemical regulations and public health policy in Europe and beyond. We outline six strategic objectives and a roadmap to further strengthen HBM approaches and increase their implementation in the regulatory risk assessment of chemicals to enhance our understanding of exposure and health impacts, enabling timely and targeted policy interventions and risk management. These strategic objectives are: 1) further development of sampling strategies and sample preparation; 2) further development of chemical-analytical HBM methods; 3) improving harmonisation throughout the HBM research life cycle; 4) further development of quality control / quality assurance throughout the HBM research life cycle; 5) obtain sustained funding and reinforcement by legislation; and 6) extend target-specific communication with scientists, policymakers, citizens and other stakeholders. HBM approaches are essential in risk assessment to address scientific, regulatory and societal challenges. HBM requires full and strong support from the scientific and regulatory domain to reach its full potential in public and occupational health assessment and in regulatory decision-making.
Collapse
Affiliation(s)
- Maryam Zare Jeddi
- National Institute for Public Health and the Environment (RIVM), the Netherlands.
| | - Nancy B Hopf
- Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland
| | - Henriqueta Louro
- National Institute of Health Dr. Ricardo Jorge, Department of Human Genetics, Lisbon and ToxOmics - Centre for Toxicogenomics and Human Health, NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal
| | - Susana Viegas
- NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, 1600-560 Lisbon, Portugal; Comprehensive Health Research Center (CHRC), 1169-056 Lisbon, Portugal
| | - Karen S Galea
- Institute of Occupational Medicine (IOM), Research Avenue North, Riccarton, Edinburgh EH14 4AP, UK
| | - Robert Pasanen-Kase
- State Secretariat for Economic Affairs (SECO), Labour Directorate Section Chemicals and Work (ABCH), Switzerland
| | - Tiina Santonen
- Finnish Institute of Occupational Health (FIOH), P.O. Box 40, FI-00032 Työterveyslaitos, Finland
| | - Vicente Mustieles
- University of Granada, Center for Biomedical Research (CIBM), School of Medicine, Department of Radiology and Physical Medicine, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Madrid, Spain
| | - Mariana F Fernandez
- University of Granada, Center for Biomedical Research (CIBM), School of Medicine, Department of Radiology and Physical Medicine, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Madrid, Spain
| | - Hans Verhagen
- University of Ulster, Coleraine, Northern Ireland, National Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark
| | | | | | - Arthur David
- Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), UMR_S 1085, F-35000 Rennes, France
| | - Hans Mol
- Wageningen Food Safety Research - part of Wageningen University & Research, Wageningen, the Netherlands
| | - Robert Barouki
- Université Paris Cité, T3S, Inserm Unit 1124, 45 rue des Saints Pères, 75006 Paris, France
| | - Karine Audouze
- Université Paris Cité, T3S, Inserm Unit 1124, 45 rue des Saints Pères, 75006 Paris, France
| | - Radu-Corneliu Duca
- Department of Health Protection, Laboratoire national de santé (LNS), 1, Rue Louis Rech, 3555 Dudelange, Luxembourg; Environment and Health, Department of Public Health and Primary Care, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
| | - Peter Fantke
- Quantitative Sustainability Assessment, Department of Environmental and Resource Engineering, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark
| | - Paul Scheepers
- Radboud Institute for Biological and Environmental Sciences, Radboud University, Nijmegen, the Netherlands
| | - Manosij Ghosh
- Environment and Health, Department of Public Health and Primary Care, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
| | - An Van Nieuwenhuyse
- Department of Health Protection, Laboratoire national de santé (LNS), 1, Rue Louis Rech, 3555 Dudelange, Luxembourg; Environment and Health, Department of Public Health and Primary Care, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
| | - Joana Lobo Vicente
- EEA - European Environment Agency, Kongens Nytorv 6, 1050 Copenhagen K, Denmark
| | - Xenia Trier
- SPF - Santé Publique France, Environmental and Occupational Health Division, France
| | - Loïc Rambaud
- SPF - Santé Publique France, Environmental and Occupational Health Division, France
| | - Clémence Fillol
- SPF - Santé Publique France, Environmental and Occupational Health Division, France
| | - Sebastien Denys
- SPF - Santé Publique France, Environmental and Occupational Health Division, France
| | - André Conrad
- German Environment Agency (Umweltbundesamt), Dessau-Roßlau/Berlin, Germany
| | | | - Alicia Paini
- European Commission, Joint Research Centre (JRC), Ispra, Italy
| | - Jon Arnot
- ARC Arnot Research and Consulting, Inc., Toronto ONM4M 1W4, Canada
| | - Florian Schulze
- European Center for Environmental Medicine, Weserstr. 165, 12045 Berlin, Germany
| | - Kate Jones
- HSE - Health and Safety Executive, Harpur Hill, Buxton SK17 9JN, UK
| | | | | | - Lorraine Brennan
- School of Agriculture and Food Science, Institute of Food and Health, University College Dublin, Dublin, Ireland
| | - Emilio Benfenati
- Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milano, Italy
| | - Francesco Cubadda
- Istituto Superiore di Sanità - National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy
| | - Alberto Mantovani
- Istituto Superiore di Sanità - National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy
| | - Alena Bartonova
- NILU Norwegian Institute for Air Research, 2027 Kjeller, Norway
| | - Alison Connolly
- Centre for Climate and Air Pollution Studies, Physics, School of Natural Science and the Ryan Institute, University of Galway, University Road, Galway H91 CF50, Ireland
| | - Jaroslav Slobodnik
- NORMAN Association, Rue Jacques Taffanel - Parc Technologique ALATA, 60550 Verneuil-en-Halatte, France
| | - Yuri Bruinen de Bruin
- Commission, Joint Research Centre, Directorate for Space, Security and Migration, Geel, Belgium
| | - Jacob van Klaveren
- National Institute for Public Health and the Environment (RIVM), the Netherlands
| | - Nicole Palmen
- National Institute for Public Health and the Environment (RIVM), the Netherlands
| | - Hubert Dirven
- Department of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
| | - Trine Husøy
- Department of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
| | - Cathrine Thomsen
- Department of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
| | - Ana Virgolino
- Environmental Health Behaviour Lab, Instituto de Saúde Ambiental, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal; Laboratório Associado TERRA, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal
| | - Martin Röösli
- Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute (Swiss TPH), CH-4123 Allschwil, Switzerland
| | - Tim Gant
- Center for Radiation, Chemical and Environmental Hazards, Public Health England, UK
| | | | - Jos Bessems
- VITO HEALTH, Flemish Institute for Technological Research, 2400 Mol, Belgium
| |
Collapse
|